These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2108652)

  • 1. Interferon gamma and tumor necrosis factor alpha. Use in gram-negative infection after shock.
    Malangoni MA; Livingston DH; Sonnenfeld G; Polk HC
    Arch Surg; 1990 Apr; 125(4):444-6. PubMed ID: 2108652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing antibiotic dose decreases polymicrobial infection after hemorrhagic shock.
    Livingston DH; Malangoni MA
    Surg Gynecol Obstet; 1993 May; 176(5):418-22. PubMed ID: 8480263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune enhancement by tumor necrosis factor-alpha improves antibiotic efficacy after hemorrhagic shock.
    Livingston DH; Malangoni MA; Sonnenfeld G
    J Trauma; 1989 Jul; 29(7):967-70; discussion 970-1. PubMed ID: 2501510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    Arch Surg; 1993 Jan; 128(1):73-7; discussion 77-8. PubMed ID: 8418784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma restores immune competence after hemorrhagic shock.
    Livingston DH; Malangoni MA
    J Surg Res; 1988 Jul; 45(1):37-43. PubMed ID: 3134579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental liver cancer: improved response after hepatic artery ligation and infusion of tumor necrosis factor-alpha and interferon-gamma.
    Yang R; Liu Q; Rescorla FJ; Grosfeld JL
    Surgery; 1995 Oct; 118(4):768-72; discussion 772-4. PubMed ID: 7570335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs.
    Eggimann P; Chioléro R; Chassot PG; Lienard D; Gerain J; Lejeune F
    Chest; 1995 Apr; 107(4):1074-82. PubMed ID: 7705119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of glucan and cefoxitin in prevention of murine abscess.
    Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
    Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic antitumor effects of rat gamma-interferon and human tumor necrosis factor alpha against androgen-dependent and -independent rat prostatic tumors.
    van Moorselaar RJ; Hendriks BT; van Stratum P; van der Meide PH; Debruyne FM; Schalken JA
    Cancer Res; 1991 May; 51(9):2329-34. PubMed ID: 1901759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
    Shah P; van der Meide PH; Borman T; Schroeder N; Bliss JM; Coombes RC
    Br J Cancer; 1989 Feb; 59(2):206-9. PubMed ID: 2495016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
    Brook I
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S425-6. PubMed ID: 8324161
    [No Abstract]   [Full Text] [Related]  

  • 13. IFN-gamma involvement in the severity of gram-negative infections in mice.
    Kohler J; Heumann D; Garotta G; LeRoy D; Bailat S; Barras C; Baumgartner JD; Glauser MP
    J Immunol; 1993 Jul; 151(2):916-21. PubMed ID: 8335919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma; toxicity is reduced by indomethacin.
    Marquet RL; Ijzermans JN; De Bruin RW; Fiers W; Jeekel J
    Int J Cancer; 1987 Oct; 40(4):550-3. PubMed ID: 3117712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
    Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
    Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma reverses bone marrow inhibition following hemorrhagic shock.
    Livingston DH
    Arch Surg; 1991 Jan; 126(1):100-3. PubMed ID: 1898696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of recombinant human TNF and interferon-gamma in four patients with refractory AML.
    Fiedler W; Weh HJ; Hossfeld DK
    Eur J Haematol; 1992 Feb; 48(2):115-6. PubMed ID: 1547873
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8).
    Nanes MS; McKoy WM; Marx SJ
    Endocrinology; 1989 Jan; 124(1):339-45. PubMed ID: 2491807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat bladder tumor (RBT323) growth by tumor necrosis factor alpha and interferon-gamma in vivo.
    van Moorselaar RJ; Hendriks BT; Borm G; van der Meide PH; Debruyne FM; Schalken JA
    J Urol; 1992 Aug; 148(2 Pt 1):458-62. PubMed ID: 1635157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.